Acetylsalicylic acid Completed Phase 4 Trials for Myocardial Ischemia / Coronary Heart Disease (CHD) / Coronary Artery Disease / Coronary Artery Stenosis / Coronary Artery Restenosis / Vascular Diseases / Chronic Total Occlusion of Coronary Artery Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01106534XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
NCT01589978PROMUS Element Plus US Post-Approval Study
NCT02567461Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
NCT02201394Reversing Ticagrelor's Effects With Fresh Platelets
NCT00484926Association of Clopidogrel Therapy and Stent Thrombosis
NCT00590174Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation
NCT00343876Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial
NCT02383771Reversal of the Anti-platelet Effects of Ticagrelor
NCT01514227Nobori Dual Antiplatelet Therapy as Appropriate Duration
NCT00977938The Dual Antiplatelet Therapy Study (DAPT Study)
NCT01192724Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation
NCT01186146Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)
NCT01102439Clopidogrel/Aspirin Interaction Study
NCT02607436Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease
NCT01830491Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients
NCT00947843Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
NCT02219412Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy